Global Competitor Insights for Peripheral Vascular Disease 2008

Table of Contents

EXECUTIVE SUMMARY

METHODOLOGY

1.0 GLOBAL PERIPHERAL VASCULAR DEVICE MARKET

• 1.1 Market Overview
  • 1.1.1 Procedures
  • 1.1.2 Peripheral Vascular Devices
  • 1.1.2.1 Peripheral Vascular Stents
  • 1.1.2.2 Percutaneous Transluminal Angioplasty Balloon Catheters
  • 1.1.2.3 Embolic Protection Devices
  • 1.1.2.4 Inferior Vena Cava Filters
  • 1.1.2.5 Aortic Stent Grafts
  • 1.1.2.6 Peripheral Vascular Accessory Devices
• 1.2 Regional Analysis
  • 1.2.1 Global Analysis
  • 1.2.2 US Analysis
  • 1.2.3 Europe Analysis
  • 1.2.4 Japan Analysis

2.0 CORDIS (JOHNSON & JOHNSON)

• 2.1 Company Overview
  • 2.1.1 Recent Events
  • 2.1.2 Company Analysis
  • 2.1.3 S.W.O.T. Analysis
  • 2.1.3.1 Strengths
  • 2.1.3.2 Weaknesses
  • 2.1.3.3 Opportunities
  • 2.1.3.4 Threats
• 2.2 Peripheral Vascular Device Profile
  • 2.2.1 Peripheral Vascular Stent Summary
  • 2.2.2 PTA Balloon Catheter Summary
  • 2.2.3 Embolic Protection Device Summary
  • 2.2.4 Inferior Vena Cava Filter Summary
  • 2.2.5 Peripheral Vascular Accessory Device Summary

3.0 BOSTON SCIENTIFIC

• 3.1 Company Overview
  • 3.1.1 Recent Events
  • 3.1.2 Company Analysis
  • 3.1.3 S.W.O.T. Analysis
  • 3.1.3.1 Strengths
  • 3.1.3.2 Weaknesses
  • 3.1.3.3 Opportunities
  • 3.1.3.4 Threats
• 3.2 Peripheral Vascular Device Profile
  • 3.2.1 Peripheral Vascular Stent Summary
  • 3.2.2 PTA Balloon Catheter Summary
  • 3.2.3 Embolic Protection Device Summary
  • 3.2.4 Inferior Vena Cava Filter Summary
  • 3.2.5 Peripheral Vascular Accessory Device Summary

4.0 W.L. GORE

• 4.1 Company Overview
  • 4.1.1 Recent Events
  • 4.1.2 Company Analysis
  • 4.1.3 S.W.O.T. Analysis
  • 4.1.3.1 Strengths
  • 4.1.3.2 Weaknesses
  • 4.1.3.3 Opportunities
  • 4.1.3.4 Threats
• 4.2 Peripheral Vascular Device Profile
  • 4.2.1 Peripheral Vascular Stent Device Summary
  • 4.2.2 Embolic Protection Device Summary
  • 4.2.3 Aortic Stent Graft Summary

5.0 COOK MEDICAL

• 5.1 Company Overview
  • 5.1.1 Recent Events
  • 5.1.2 Company Analysis
  • 5.1.3 S.W.O.T. Analysis
  • 5.1.3.1 Strengths
  • 5.1.3.2 Weaknesses
  • 5.1.3.3 Opportunities
  • 5.1.3.4 Threats
• 5.2 Peripheral Vascular Device Profile
  • 5.2.1 Peripheral Vascular Stent Summary
  • 5.2.2 PTA Balloon Catheter Summary
  • 5.2.3 Inferior Vena Cava Filter Summary
  • 5.2.4 Aortic Stent Graft Summary
  • 5.2.5 Peripheral Vascular Accessory Device Summary

6.0 ABBOTT VASCULAR

• 6.1 Company Overview
  • 6.1.1 Recent Events
  • 6.1.2 Company Analysis
  • 6.1.3 S.W.O.T. Analysis
  • 6.1.3.1 Strengths
  • 6.1.3.2 Weaknesses
  • 6.1.3.3 Opportunities
  • 6.1.3.4 Threats
• 6.2 Peripheral Vascular Device Profile
  • 6.2.1 Peripheral Vascular Stent Device Summary
  • 6.2.2 PTA Balloon Catheter Summary
  • 6.2.3 Embolic Protection Device Summary
  • 6.2.4 Peripheral Vascular Accessory Device Summary

7.0 C. R. BARD

• 7.1 Company Overview
  • 7.1.1 Recent Events
  • 7.1.2 Company Analysis
  • 7.1.3 S.W.O.T. Analysis
  • 7.1.3.1 Strengths
  • 7.1.3.2 Weaknesses
  • 7.1.3.3 Opportunities
  • 7.1.3.4 Threats
  • 7.2 Peripheral Vascular Device Profile
  • 7.2.1 Peripheral Vascular Stent Summary
  • 7.2.2 PTA Balloon Catheter Summary
  • 7.2.3 Inferior Vena Cava Filter Summary

8.0 MEDTRONIC

• 8.1 Company Overview
  • 8.1.1 Recent Events
  • 8.1.2 Company Analysis
  • 8.1.3 S.W.O.T. Analysis
  • 8.1.3.1 Strengths
  • 8.1.3.2 Weaknesses
  • 8.1.3.3 Opportunities
  • 8.1.3.4 Threats
• 8.2 Peripheral Vascular Device Profile
  • 8.2.1 Peripheral Vascular Stent Summary
  • 8.2.2 Embolic Protection Device Summary
  • 8.2.3 Aortic Stent Graft Summary

9.0 TERUMO MEDICAL

• 9.1 Company Overview
  • 9.1.1 Recent Events
  • 9.1.2 Company Analysis
  • 9.1.3 S.W.O.T. Analysis
  • 9.1.3.1 Strengths
  • 9.1.3.2 Weaknesses
  • 9.1.3.3 Opportunities
  • 9.1.3.4 Threats
• 9.2 Peripheral Vascular Device Profile
  • 9.2.1 Aortic Stent Graft Device Summary
  • 9.2.2 Peripheral Vascular Accessory Device Summary

10.0 EV3

• 10.1 Company Overview
  • 10.1.1 Recent Events
  • 10.1.2 Company Analysis
  • 10.1.3 S.W.O.T. Analysis
  • 10.1.3.1 Strengths
  • 10.1.3.2 Weaknesses
  • 10.1.3.3 Opportunities
  • 10.1.3.4 Threats
• 10.2 Peripheral Vascular Device Profile
  • 10.2.1 Peripheral Vascular Stent Summary
  • 10.2.2 PTA Balloon Catheter Summary
  • 10.2.3 Embolic Protection Device Summary
  • 10.2.4 Peripheral Vascular Accessory Device Summary

APPENDIX A: MRG ACRONYMS AND INITIALISMS